Molinalogo

Measure

2022

2023

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

64.12%

65.12%

64.90%

Annual Dental Visits (ADV) Total

NB

NB

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

44.42%

46.35%

46.74%

Appropriate Testing for Pharyngitis (CWP)

76.86%

75.10%

77.56%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

96.02%

95.88%

93.08%

Asthma Medication Ratio (AMR) Total

68.90%

78.47%

69.41%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

65.14%

73.01%

66.19%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

72.75%

72.26%

68.61%

Breast Cancer Screening (BCS)

46.94%

48.71%

55.25%

Cervical Cancer Screening (CCS)

56.69%

59.12%

59.85%

Childhood Immunization Status (CIS) Combination #10

36.98%

32.60%

35.04%

Chlamydia Screening in Women (CHL) Total

50.63%

50.48%

61.07%

Controlling High Blood Pressure (CBP)

65.45%

61.31%

65.45%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

79.46%

78.84%

80.86%

Eye Exam for Patients With Diabetes (EED)

54.50%

50.61%

56.20%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

21.97%

33.01%

27.73%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

52.51%

51.41%

46.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

43.28%

39.34%

41.03%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

37.96%

37.26%

37.31%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

55.19%

55.69%

57.90%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

51.58%

53.77%

55.72%

Immunizations for Adolescents (IMA) Combination #2

31.14%

30.66%

38.93%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

16.07%

16.07%

16.94%

Kidney Health Evaluation for Patients with Diabetes (KED)

43.24%

41.49%

38.80%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Total

28.68%

28.52%

39.01%

Pharmacotherapy for Opioid Use Disorder (POD) Total

13.00%

13.95%

31.93%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

75.03%

77.22%

75.79%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

87.06%

87.21%

86.96%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

82.61%

83.14%

≤ 92.72%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

88.81%

90.27%

86.86%

Prenatal and Postpartum Care (PPC) Postpartum Care

79.08%

82.00%

80.78%

Prenatal Immunization Status (PRS) Combination Rate

32.72%

28.47%

25.81

Risk of Continued Opioid Use (COU) 31-Day Total

2.03%

1.97%

≤ 2.45%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

83.03%

82.24%

81.64%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

68.70%

71.02%

73.63%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

65.89%

63.98%

67.07%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

66.84%

68.31%

70.37%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

63.59%

59.03%

63.89%

Use of Imaging Studies for Low Back Pain (LBP)

74.14%

73.15%

75.44%

Use of Opioids at High Dosage (HDO)

4.87%

4.46%

≤ 2.19%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

2.45%

2.24%

≤ 0.87%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

74.70%

76.64%

83.21%